BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 31721454)

  • 1. Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma.
    Suzuki M; Muroi A; Nojima M; Numata A; Takasaki H; Sakai R; Yokose T; Miyagi Y; Koshikawa N
    Proteomics Clin Appl; 2020 Jan; 14(1):e1900091. PubMed ID: 31721454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rare Case of Ovarian Double-Hit/Diffuse Large B-Cell Lymphoma: A Case Report and Review of Literature.
    Urella M; Nwanwene K; Sidda A; Pacioles T
    J Investig Med High Impact Case Rep; 2023; 11():23247096231154641. PubMed ID: 36840472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial classic Hodgkin lymphoma and subsequent diffuse large B-cell lymphoma: separate entities with a continuum of BCL2 rearrangement.
    Gehris BT; Wang WJ; Mai B; Chen L; Wang W; Hu Z
    Pathology; 2024 Feb; 56(1):115-118. PubMed ID: 37573163
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma.
    Hoppe MM; Jaynes P; Shuangyi F; Peng Y; Sridhar S; Hoang PM; Liu CX; De Mel S; Poon L; Chan EHL; Lee J; Ong CK; Tang T; Lim ST; Nagarajan C; Grigoropoulos NF; Tan SY; Hue SS; Chang ST; Chuang SS; Li S; Khoury JD; Choi H; Harris C; Bottos A; Gay LJ; Runge HFP; Moutsopoulos I; Mohorianu I; Hodson DJ; Farinha P; Mottok A; Scott DW; Pitt JJ; Chen J; Kumar G; Kannan K; Chng WJ; Chee YL; Ng SB; Tripodo C; Jeyasekharan AD
    Cancer Discov; 2023 May; 13(5):1144-1163. PubMed ID: 37071673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.
    Quentmeier H; Drexler HG; Hauer V; MacLeod RA; Pommerenke C; Uphoff CC; Zaborski M; Berglund M; Enblad G; Amini RM
    PLoS One; 2016; 11(12):e0167599. PubMed ID: 27907212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression.
    Foda AAM; Atia T; Sakr HI; Abd Elaziz Ahmed Elnaghi K; Abdelhay WM; Enan ET
    J Evid Based Integr Med; 2023; 28():2515690X231198315. PubMed ID: 37654084
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine.
    Araf S; Korfi K; Rahim T; Davies A; Fitzgibbon J
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1093-1102. PubMed ID: 27648481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma.
    Harkins RA; Chang A; Patel SP; Lee MJ; Goldstein JS; Merdan S; Flowers CR; Koff JL
    Expert Rev Hematol; 2019 Nov; 12(11):959-973. PubMed ID: 31513757
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.
    Mottok A; Wright G; Rosenwald A; Ott G; Ramsower C; Campo E; Braziel RM; Delabie J; Weisenburger DD; Song JY; Chan WC; Cook JR; Fu K; Greiner T; Smeland E; Holte H; Savage KJ; Glinsmann-Gibson BJ; Gascoyne RD; Staudt LM; Jaffe ES; Connors JM; Scott DW; Steidl C; Rimsza LM
    Blood; 2018 Nov; 132(22):2401-2405. PubMed ID: 30257882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins.
    Hiratsuka T; Ito S; Sakai R; Yokose T; Endo T; Daigo Y; Miyagi Y; Tsuruyama T
    Clin Proteomics; 2023 Sep; 20(1):36. PubMed ID: 37705009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large b-cell lymphoma of the ocular adnexa with flow cytometry analysis and review of the literature.
    Mitamura M; Kase S; Suzuki Y; Sakaguchi T; Suimon Y; Sinohara T; Shimizu AI; Matsuno Y; Sakai H; Kase M; Ishida S
    Eur J Ophthalmol; 2022 Sep; ():11206721221127053. PubMed ID: 36114636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Cavernous Sinus Syndrome Due to Extranodal Diffuse Large B-Cell Lymphoma.
    Kim TR; Bae KN; Son JH; Shin K; Kim H; Ko H; Kim B; Kim MB
    Ann Dermatol; 2023 Nov; 35(Suppl 2):S300-S303. PubMed ID: 38061726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary diffuse large B-cell lymphoma of the prostate: Histopathological diagnosis of a rare entity in the prostate.
    Sharma R; Bansal S; Gangoli A
    Indian J Pathol Microbiol; 2024 Feb; ():. PubMed ID: 38427765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and genetic subclassification comparison of diffuse large B-cell lymphoma (DLBCL) - real-life experience with 74 cases.
    Ivanova VS; Vela V; Dirnhofer S; Dobbie M; Stenner F; Knoblich J; Tzankov A; Menter T
    Pathobiology; 2023 Dec; ():. PubMed ID: 38128501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers.
    Fan J; Thanedar S; Ovechko V; Jana B
    Case Rep Oncol; 2024; 17(1):517-523. PubMed ID: 38549625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Still Far to Go With Characterisation of Molecular and Genetic Features of Diffuse Large B-Cell Lymphoma in People Living With HIV: A Scoping Review.
    Manyau MCP; Zambuko B; Chatambudza M; Zhou DT; Manasa J
    Oncol Rev; 2024; 18():1375291. PubMed ID: 38707485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse large B-cell lymphoma with DNA copy number changes in a Japanese black calf.
    Maezawa M; Watanabe KI; Kobayashi Y; Yoshida K; Chambers JK; Uchida K; Maruyama R; Inokuma H
    Vet Res Commun; 2024 Apr; ():. PubMed ID: 38575802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable slope normalization of reverse phase protein arrays.
    Neeley ES; Kornblau SM; Coombes KR; Baggerly KA
    Bioinformatics; 2009 Jun; 25(11):1384-9. PubMed ID: 19336447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reverse phase protein array based phospho-antibody characterization approach and its applicability for clinical derived tissue specimens.
    Wang N; Zhang L; Ying Q; Song Z; Lu A; Treumann A; Liu Z; Sun T; Ding Z
    Sci Rep; 2022 Dec; 12(1):22373. PubMed ID: 36572710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and protein markers distinguishing the "polymerase epsilon exonuclease" from the "copy number low" subtype of endometrial cancer.
    Kim K; Hwangbo S; Kim H; Kim YB; No JH; Suh DH; Park T
    J Gynecol Oncol; 2022 May; 33(3):e27. PubMed ID: 35128857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.